Related Experiment Video
Updated: Mar 18, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
Study of streptomycin-induced ototoxicity: protocol for a longitudinal study.
Adebolajo A Adeyemo1, Odunayo Oluwatosin2, Olayemi O Omotade1
1Institute of Child Health, College of Medicine, University of Ibadan, PMB 5017, Ibadan, Nigeria.
This study investigates streptomycin ototoxicity in tuberculosis patients, revealing key predictors and mitochondrial gene mutations. Findings will inform public health strategies for aminoglycoside use and TB treatment adherence.
Area of Science:
- Ototoxicology
- Genetics
- Public Health
Background:
- Aminoglycosides, like streptomycin, can cause hearing loss (ototoxicity), particularly in individuals with specific mitochondrial gene mutations.
- Unregulated aminoglycoside use in developing nations exacerbates hearing impairment burdens, yet data for policy changes is scarce.
- Streptomycin is crucial for tuberculosis retreatment, making its ototoxicity a significant concern for patient adherence and public health.
Purpose of the Study:
- To determine the incidence and predictors of streptomycin-induced ototoxicity in tuberculosis retreatment patients.
- To identify mitochondrial gene mutations associated with aminoglycoside ototoxicity in an African population.
- To provide data for informing public health policies on aminoglycoside use and optimizing tuberculosis treatment adherence.
Main Methods:
- Longitudinal recruitment of tuberculosis retreatment patients from Directly Observed Treatment, Short-course centers.
- Comprehensive audiologic assessments pre- and post-treatment, with early ototoxicity detection via American Speech and Hearing Association criteria.
- Genetic analysis for mitochondrial gene mutations and statistical analysis including Kaplan-Meier curves and Cox proportional hazards tests.
Main Results:
- Analysis of ototoxicity incidence and associated risk factors, including genotype status.
- Identification of specific mitochondrial gene mutations linked to streptomycin ototoxicity in the study cohort.
- Quantification of the impact of ototoxicity on tuberculosis treatment adherence.
Conclusions:
- The study provides crucial data on the burden and predictors of aminoglycoside-induced ototoxicity in tuberculosis patients.
- Findings will guide public health strategies for regulating aminoglycoside use and managing drug-induced ototoxicity.
- Results will enhance pre-treatment counseling, potentially improving tuberculosis treatment adherence and outcomes.
More Related Videos
12:21The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
09:06Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice
Published on: January 9, 2019